OKAI — EvokAI Creative Labs Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for EvokAI Creative Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.061 | 0.066 | 0.069 | 0.362 | 13.4 |
| Operating Profit | -0.061 | -0.066 | -0.069 | -0.362 | -13.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.061 | -0.066 | -0.069 | -0.362 | -12.7 |
| Net Income After Taxes | -0.061 | -0.066 | -0.069 | -0.362 | -12.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.061 | -0.066 | -0.069 | -0.362 | -12.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.061 | -0.066 | -0.069 | -0.362 | -12.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.085 | -0.092 | -0.096 | -0.46 | -0.144 |